首页> 美国卫生研究院文献>Interactive Cardiovascular and Thoracic Surgery >Double lumen bi-cava cannula for veno-venous extracorporeal membrane oxygenation as bridge to lung transplantation in non-intubated patient
【2h】

Double lumen bi-cava cannula for veno-venous extracorporeal membrane oxygenation as bridge to lung transplantation in non-intubated patient

机译:双腔双腔插管用于静脉-静脉体外膜充氧作为非插管患者肺移植的桥梁

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Extracorporeal membrane oxygenation (ECMO) is used for refractory respiratory failure. Normally, ECMO is implanted in intubated patients as a last resort. We report the case of a non-intubated patient who benefited from veno-venous (VV) ECMO. A 35-year old cystic fibrosis man presented a severe respiratory decompensation with refractory hypercapnia. We opted for an ECMO instead of mechanical ventilation (MV). We implanted a double lumen bi-cava cannula (DLC) (Avalon EliteTM) in the right jugular vein. Before ECMO implantation, the patient presented refractory respiratory failure (pH = 7.1, PaO2 = 83 mmHg, PaCO2 = 103 mmHg). We proposed that the patient be placed on the high emergency lung transplantation waiting list after failure to wean him from ECMO. This registration was effective 10 days after ECMO implantation. The patient was grafted the next day. Under ECMO, mean PaO2, PaCO2 and TCA were 80.6 ± 14.2, 53.8 ± 6.4 mmHg and 56.2 ± 9.7 s, respectively. The patient could eat, drink, talk and practice chest physiotherapy. The evolution was uneventful under ECMO. Weaning from ECMO was done in the operating theatre after transplantation. VV ECMO with DLC is safe and feasible in non-intubated patients. It avoids potential complications of MV, and allows respiratory assistance as bridge to transplantation.
机译:体外膜氧合(ECMO)用于难治性呼吸衰竭。通常,将ECMO作为最后的手段植入插管患者体内。我们报告了一例未插管的患者受益于静脉-静脉(VV)ECMO。一名35岁的囊性纤维化男子出现严重的呼吸道代偿失调,伴有难治性高碳酸血症。我们选择了ECMO而不是机械通气(MV)。我们在右颈静脉内植入了双腔双腔插管(DLC)(Avalon Elite TM )。植入ECMO之前,患者出现难治性呼吸衰竭(pH = 7.1,PaO2 = 83mmHg,PaCO2 = 103mmHg)。我们建议将患者从ECMO撤除后,将其置于紧急肺移植急诊等候名单上。此注册在ECMO植入后10天有效。该患者第二天被移植。在ECMO下,平均PaO2,PaCO2和TCA分别为80.6±14.2、53.8±6.4 mmHg和56.2±9.7s。患者可以吃,喝,说话并进行胸部物理治疗。在ECMO的推动下,进展平稳。移植后在手术室进行ECMO的断奶。带DLC的VV ECMO在非插管患者中是安全可行的。它避免了MV的潜在并发症,并允许呼吸辅助作为移植的桥梁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号